Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia Using Cell-Free Fetal DNA in Maternal Plasma
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
CONTEXT: Congenital adrenal hyperplasia (CAH) is an autosomal recessive condition that arises from mutations in CYP21A2 gene, which encodes for the steroidogenic enzyme 21-hydroxylase. To prevent genital ambiguity in affected female fetuses, prenatal treatment with dexamethasone must begin on or before gestational week 9. Currently used chorionic villus sampling and amniocentesis provide genetic results at approximately 14 weeks of gestation at the earliest. This means that mothers who want to undergo prenatal dexamethasone treatment will be unnecessarily treating seven of eight fetuses (males and three of four unaffected females), emphasizing the desirability of earlier genetic diagnosis in utero. OBJECTIVE: The objective of the study was to develop a noninvasive method for early prenatal diagnosis of fetuses at risk for CAH. PATIENTS: Fourteen families, each with a proband affected by phenotypically classical CAH, were recruited. DESIGN: Cell-free fetal DNA was obtained from 3.6 mL of maternal plasma. Using hybridization probes designed to capture a 6-Mb region flanking CYP21A2, targeted massively parallel sequencing (MPS) was performed to analyze genomic DNA samples from parents and proband to determine parental haplotypes. Plasma DNA from pregnant mothers also underwent targeted MPS to deduce fetal inheritance of parental haplotypes. RESULTS: In all 14 families, the fetal CAH status was correctly deduced by targeted MPS of DNA in maternal plasma, as early as 5 weeks 6 days of gestation. CONCLUSIONS: MPS on 3.6 mL plasma from pregnant mothers could potentially provide the diagnosis of CAH, noninvasively, before the ninth week of gestation. Only affected female fetuses will thus be treated. Our strategy represents a generic approach for noninvasive prenatal testing for an array of autosomal recessive disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Noninvasive cell-free fetal DNA testing enables fetal sex determination and genotyping as early as 4–5 weeks of gestation, allowing prenatal therapy to be limited to affected females only (16, 100).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [100]
In the citing paper
“Prenatal sex typing (SRY detection) can be performed using PCR amplification of cell-free fetal DNA as early as week 6-9 (323)”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [323]
In the citing paper
“By using blood from both parents and an affected proband and applying massively parallel DNA sequencing coupled with extensive analysis of single nucleotide polymorphisms near the CYP21A2 gene, it was possible to determine the CYP21A2 genotype in 14 of 14 at-risk fetuses within 3 weeks of obtaining fetal DNA in maternal blood samples (99).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [99]
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 5×
“E1028 New et al Noninvasive CAH Diagnosis Using Maternal Plasma DNA J Clin Endocrinol Metab, June 2014, 99(6):E1022–E1030”
MethodInfluentialMaternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus
Lo, Y. M. D., Chan, K. C. A., Sun, H., Chen, E. Z., Jiang, P., Lun, F. M. F., Zheng, Y. W., Leung, T. Y., Lau, T. K., Cantor, C. R., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001720 · Cited by 1,101 · cited 12×
“Notably, to determine inheritance, we carried out relative haplotype dosage analysis (RHDO) (7, 8) to establish overrepresentation of the maternal and paternal haplotypes in the pregnant mother’s plasma with reference to the respective noninherited haplotypes.”
MethodSelf-citationProcedure-Related Complications of Amniocentesis and Chorionic Villous Sampling: A Systematic Review
Mujezinovic, F., & Alfirevic, Z. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000278820.54029.e3 · Cited by 446
Digital PCR for the molecular detection of fetal chromosomal aneuploidy
Lo, Y. M. D., Lun, F. M. F., Chan, K. C. A., Tsui, N. B. Y., Chong, K. C., Lau, T. K., Leung, T. Y., Zee, B. C. Y., Cantor, C. R., & Chiu, R. W. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705765104 · Cited by 434 · cited 11×
“We thus proceeded to investigate in silico the effects of varying fractional fetal DNA concentrations on the SPRT analysis (see Supplemental Methods and Supplemental Table 3).”
MethodSelf-citationPang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392 · cited 1×
“Affecting 1 of 15 000 live births worldwide (1, 2), the disease is characterized by varying levels of impairments in mineralocorticoid and glucocorticoid synthesis, over-”
BackgroundNew, M. I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Sun, L., Zaidi, M., Wilson, R. C., & Yuen, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300057110 · Cited by 365 · cited 5×
“Remarkably, both children had the same mutation, del/ V281L, but had variable phenotypes (2, 4).”
BackgroundSelf-citationWhere the crossovers are: recombination distributions in mammals
Kauppi, L., Jeffreys, A. J., & Keeney, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1346 · Cited by 307 · cited 1×
“These results could most likely be explained by a recombination event in a major histocompatibility complex class II recombination hot spot (12, 13), which we confirmed with targeted MPS on the newborn’s DNA.”
BackgroundTsui, N. B. Y., Kadir, R. A., Chan, K. C. A., Chi, C., Mellars, G., Tuddenham, E. G., Leung, T. Y., Lau, T. K., Chiu, R. W. K., & Lo, Y. M. D. (2011) · Blood · doi:10.1182/blood-2010-10-310789 · Cited by 260 · cited 1×
“(21), cystic fibrosis (22), and Gaucher disease (23).”
BackgroundSelf-citationPang, S., Wallace, M. A., Hofman, L. F., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · PEDIATRICS · doi:10.1542/peds.81.6.866 · Cited by 191
Lam, K.-W. G., Jiang, P., Liao, G. J. W., Chan, K. C. A., Leung, T. Y., Chiu, R. W. K., & Lo, Y. M. D. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.189589 · Cited by 189 · cited 13×
“ssemia (8), 11 -hydroxylase deficiency (20), hemophilia”
MethodSelf-citation
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Sun, K., Jiang, P., Chan, K. C. A., Wong, J., Cheng, Y. K. Y., Liang, R. H. S., Chan, W.-K., Ma, E. S. K., Chan, S. L., Cheng, S. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508736112 · Cited by 774
Self-citationCongenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics
Jiang, P., & Lo, Y. M. D. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.03.009 · Cited by 312
Self-citation
Metadata
- Authors
- New, M. I., Tong, Y. K., Yuen, T., Jiang, P., Pina, C., Chan, K. C. A., Khattab, A., Liao, G. J. W., Yau, M., Kim, S.-M., Chiu, R. W. K., Sun, L., Zaidi, M., & Lo, Y. M.
- Affiliations
- Mount Sinai Hospital (US)
- Chinese University of Hong Kong (HK)
- Corresponding author
- New, Maria I.
- Lo, Y. M.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-06-01
- Volume
- 99
- Issue
- 6
- Pages
- E1022-E1030
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4037720
- OpenAlex
- W2097351942
- Cited by
- 319
- References
- 28
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 18 · 2023: 23 · 2022: 15 · 2021: 18 · 2020: 15 · 2019: 23 · 2018: 32 · 2017: 88 · 2016: 25 · 2015: 36 · 2014: 8
- FWCI
- 49.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG040132, AG-23176, AG40132, R01AG023176)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK80459, R01DK080459)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR65932, R01AR065932)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- congenital adrenal hyperplasia, noninvasive prenatal diagnosis, cell-free fetal DNA, maternal plasma, CYP21A2, 21-hydroxylase, haplotype analysis, targeted sequencing, autosomal recessive disorder
- MeSH terms
- Adrenal Hyperplasia, Congenital, Base Sequence, Cell-Free System, DNA, DNA Mutational Analysis, Female, Fetus, Humans, Pedigree, Pregnancy, Prenatal Diagnosis, Steroid 21-Hydroxylase, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia Using Cell-Free Fetal DNA in Maternal Plasma. https://app.cochat.ai/papers/10.1210/jc.2014-1118
- The paper
- New, M. I., Tong, Y. K., Yuen, T., Jiang, P., Pina, C., Chan, K. C. A., Khattab, A., Liao, G. J. W., Yau, M., Kim, S.-M., Chiu, R. W. K., Sun, L., Zaidi, M., & Lo, Y. M. (2014). Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia Using Cell-Free Fetal DNA in Maternal Plasma. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2014-1118
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.